Betti, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 2.511
EU - Europa 1.094
AS - Asia 725
SA - Sud America 98
Continente sconosciuto - Info sul continente non disponibili 34
AF - Africa 16
OC - Oceania 4
Totale 4.482
Nazione #
US - Stati Uniti d'America 2.484
DE - Germania 441
SG - Singapore 372
IT - Italia 187
CN - Cina 177
SE - Svezia 97
GB - Regno Unito 94
BR - Brasile 76
FR - Francia 76
UA - Ucraina 74
VN - Vietnam 45
IE - Irlanda 35
FI - Finlandia 26
IN - India 24
ID - Indonesia 22
PL - Polonia 16
HK - Hong Kong 15
TR - Turchia 15
RU - Federazione Russa 14
CA - Canada 13
JP - Giappone 13
AR - Argentina 9
IQ - Iraq 8
BD - Bangladesh 7
MX - Messico 6
BE - Belgio 5
NL - Olanda 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
AU - Australia 4
CL - Cile 4
HU - Ungheria 4
IR - Iran 4
MA - Marocco 4
AT - Austria 3
LT - Lituania 3
VE - Venezuela 3
AZ - Azerbaigian 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
JO - Giordania 2
PH - Filippine 2
PK - Pakistan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AW - Aruba 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ES - Italia 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KW - Kuwait 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TZ - Tanzania 1
Totale 4.449
Città #
Singapore 213
Chandler 210
Ashburn 89
San Jose 89
Rome 54
Cattolica 52
Beijing 48
Jacksonville 41
Ann Arbor 35
Dublin 35
Dearborn 33
San Mateo 31
Atlanta 30
Los Angeles 29
Munich 29
Nanjing 27
Wilmington 24
Houston 23
Nürnberg 22
Redmond 22
Dallas 21
Jakarta 19
Marseille 19
New York 19
Boston 18
Lauterbourg 18
Milan 16
Lawrence 15
Ho Chi Minh City 13
Hanoi 11
Hong Kong 11
Kraków 11
Nanchang 11
Redwood City 11
Boardman 10
Frankfurt am Main 10
Hebei 10
São Paulo 10
Woodbridge 10
Fairfield 9
Tokyo 9
Memphis 8
Chicago 7
Orem 7
Santa Clara 7
Tianjin 7
Turku 7
Phoenix 6
Shenyang 6
The Dalles 6
Bremen 5
Leawood 5
Mountain View 5
Rio de Janeiro 5
Brussels 4
Cambridge 4
Changsha 4
Columbus 4
Council Bluffs 4
Denver 4
Fremont 4
Guangzhou 4
Haiphong 4
Imphal 4
Istanbul 4
Izmir 4
Jiaxing 4
Moscow 4
Poplar 4
Princeton 4
Seattle 4
Simi Valley 4
Toronto 4
Vladivostok 4
Zhengzhou 4
Budapest 3
Des Moines 3
Detroit 3
Hangzhou 3
Jinan 3
Johannesburg 3
Kunming 3
Montreal 3
Naples 3
Nuremberg 3
Portsmouth 3
Salvador 3
Sheffield 3
University Park 3
Warsaw 3
Washington 3
Amman 2
Amsterdam 2
Ankara 2
Baghdad 2
Baku 2
Belo Horizonte 2
Bologna 2
Brooklyn 2
Buenos Aires 2
Totale 1.648
Nome #
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 452
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 373
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 317
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 305
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 299
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis) 288
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study 246
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 246
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 232
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia 232
High Frequency of Germline ATM Variants in Familial Philadelphia-Negative Myeloproliferative Neoplasms 192
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 178
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy 169
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 162
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy. 144
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 142
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 130
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 128
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 127
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms 105
TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-Analysis 15
Totale 4.482
Categoria #
all - tutte 13.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022157 0 13 1 7 7 3 0 27 8 16 30 45
2022/2023452 52 78 42 79 25 56 22 27 56 2 4 9
2023/2024144 12 45 3 6 4 23 4 7 0 12 17 11
2024/2025345 7 19 23 18 49 4 3 26 62 26 50 58
2025/2026861 119 19 43 64 204 52 128 33 47 60 69 23
2026/20271.466 40 1.426 0 0 0 0 0 0 0 0 0 0
Totale 4.482